About Us

Lewis C. Cantley, Ph.D., is Professor of Medicine at the Dana Farber Cancer Institute and Professor of Cell Biology at Harvard Medical School.  He obtained a Ph.D. in biophysical chemistry from Cornell University and did postdoctoral training at Harvard University.  Previously the Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College and New York Presbyterian Hospital, Dr. Cantley has also taught and performed research in biochemistry, physiology and cancer biology at Tufts University School of Medicine and at Beth Israel Deaconess Medical Center and Harvard Medical School.  His laboratory discovered the PI 3-Kinase pathway that plays a critical role in insulin signaling and in cancers.  Dr. Cantley is a member of the National Academy of Sciences and National Academy of Medicine and has received a number of awards for his research, most recently the 2019 Horwitz Prize.  He has founded several companies, including Larkspur Biosciences.

Nathanael Gray, Ph.D., is the Krishnan-Shah Professor of Chemical and Systems Biology at Stanford, Co-Director of Cancer Drug Discovery, Co-Leader of the Cancer Therapeutics Research Program, Member of Chem-H, and Program Leader for Small Molecule Drug Discovery for the Innovative Medicines Accelerator (IMA). His research uses the tools of synthetic chemistry, protein biochemistry, and cancer biology to discover and validate new strategies for addressing anti-cancer targets. Dr. Gray’s research has had broad impact in the areas of kinase inhibitor and degrader design and in circumventing drug resistance. Dr. Gray received his PhD in organic chemistry from the University of California at Berkeley.  Dr. Gray has also been involved in establishing new companies to advance projects from the lab into the commercial sector including Larkspur Biosciences.  His contributions have been recognized through numerous awards including the Paul Marks Prize in 2019.

Vijay Kuchroo, DVM, Ph.D., is the Samuel L. Wasserstrom Professor of Neurology at Harvard Medical School and Senior Scientist at Brigham and Women’s Hospital.  He is also an Institute member of the Broad Institute, and a participant in a Klarman Cell Observatory project that focuses on T cell differentiation. He is the founding Director of the Evergrande Center for Immunologic Diseases at Harvard Medical School and Brigham and Women’s Hospital. His major research interests include autoimmune diseases, cancer, and neuroimmunology.  Dr. Kuchroo obtained his Ph.D. at the University of Queensland. Dr. Kuchroo has 25 patents and has founded five different biotech companies including Larkspur Biosciences.